Final Evidence Report and Meeting Summary
New England CEPAC
SMA: Final Evidence Report
ICER’s final report on treatments for SMA, including a summary of the public meeting and key policy recommendations.
NOTE: An update was added to this report on May 24, 2019, to reflect the FDA label and new clinical data for Zolgensma.View All Materials on this Topic or Go Back to View More Materials